Fig. 3From: Targeting liver cancer stem cell through EpCAM therapy targeted with chemotherapy endorse enhanced progression in hepatocellular carcinomaLiver cancer stem cell expression was drastically decreased in EpCAM-targeted therapy in single or in combination compared to control and + ve control (cisplatin treatment)Back to article page